AARD
Aardvark Therapeutics, Inc.—15-min delayed · EOD close4.92 −7.69% downas of 2026-09-09mkt cap $108M
Pharmaceutical Preparations · SIC 2834 · CIK 0001774857
Income statement
| Metric | Value | Period | Source |
|---|---|---|---|
| Operating income | −$74.0M | 2026-06-30 | 10-Q · 0001193125-26-344987 |
| Net income | −$69.9M | 2026-06-30 | 10-Q · 0001193125-26-344987 |
Balance sheet
| Metric | Value | Period | Source |
|---|---|---|---|
| Total assets | $81.5M | 2026-06-30 | 10-Q · 0001193125-26-344987 |
| Current assets | $80.7M | 2026-06-30 | 10-Q · 0001193125-26-344987 |
| Total liabilities | $6.7M | 2026-06-30 | 10-Q · 0001193125-26-344987 |
| Current liabilities | $6.4M | 2026-06-30 | 10-Q · 0001193125-26-344987 |
| Shareholders' equity | $74.8M | 2026-06-30 | 10-Q · 0001193125-26-344987 |